DBV Technologies S.A.

DBVT Biotech & pharma

Develops skin patches for children with peanut allergies.

Jun 2026Revenue $5.02M/yrExpenses $183M/yr
No trendCash runway ≈ 1.0 years from Jun 2026
Figures by year

When will DBV Technologies be profitable?

Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $5.02M and expenses $183M.

Fiscal year toRevenueExpensesOperating profit
Dec 2025$5.64M$153M−$147M
Dec 2024$4.15M$121M−$117M
Dec 2023$15.7M$92.2M−$76.4M
Dec 2022$4.84M$101M−$96.6M
Dec 2021$5.71M$104M−$98.6M
Dec 2020$11.3M$170M−$159M
Dec 2019$14.7M$186M−$171M